Oral GLP-1 Market Analysis, Demand and Growth Rate Forecast 2035
According to Payal Rabde, who specializes in orally administered therapies for type-2 diabetes, weight management, and metabolic health, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the oral GLP-1 market. The global oral GLP-1 market size was estimated at USD 6.81 billion in 2025 and is predicted to increase from USD 9.19 billion in 2026 to approximately USD 137.36 billion by 2035, expanding at a CAGR of 35.05% from 2026 to 2035. The market is growing due to rising demand for convenient weight-management and diabetes treatments, improved patient acceptance, and advancements in oral drug-delivery technologies.
Last Updated : 15 September 2026
Category: Therapeutic Area
Insight Code: 6351
Format: PDF / PPT / Excel